A5073955893- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Eosinophilic Disorders and Syndromes
- Hemoglobinopathies and Related Disorders
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- CAR-T cell therapy research
- Cancer Risks and Factors
- Acute Myeloid Leukemia Research
- Pelvic and Acetabular Injuries
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Systemic Lupus Erythematosus Research
- Multiple and Secondary Primary Cancers
- Pelvic floor disorders treatments
- Mast cells and histamine
- Chronic Myeloid Leukemia Treatments
- Erythrocyte Function and Pathophysiology
- Urticaria and Related Conditions
- Bladder and Urothelial Cancer Treatments
- Histiocytic Disorders and Treatments
- Autoimmune and Inflammatory Disorders Research
- Retinoids in leukemia and cellular processes
- Platelet Disorders and Treatments
- Atherosclerosis and Cardiovascular Diseases
- Biotin and Related Studies
Peter MacCallum Cancer Centre
2024-2025
The Royal Melbourne Hospital
2024-2025
Royal Brisbane and Women's Hospital
2024
Sullivan Nicolaides Pathology
2021-2023
Mater Adult Hospital
2021-2023
Summary Glofitamab is a CD3‐CD20 bispecific antibody used to treat B‐cell non‐Hodgkin lymphoma. We describe three cases of enterocolitis occurring with glofitamab at single institution. Similarities between include onset post cycle 4–5, moderately elevated faecal calprotectin, abnormal bowel avidity on positron emission tomography scan (2/3), absence CD20‐positive B cells gut histology and steroid responsiveness. There was variability in the area gastrointestinal inflammation, severity...
Summary Lymphoma in pregnancy (LIP) presents unique clinical, social and ethical challenges; however, the evidence regarding this clinical scenario is limited. We conducted a multicentre retrospective observational study reporting on features, management, outcomes of LIP patients diagnosed between January 2009 December 2020 at 16 sites Australia New Zealand for first time. included diagnoses occurring either during or within 12 months following delivery. A total 73 were included, 41...
Abstract Objectives Myeloid/lymphoid neoplasms with FGFR1 rearrangement are a rare group of that share features eosinophilia and lineage promiscuity. First, we described challenging case acute leukemia switch cytogenetically cryptic FGFR1. Second, aimed to systemically review this phenomenon in published literature. Methods A 68-year-old man history chemotherapy exposure presented myeloid without or 8p11 abnormalities on karyotyping. Over refractory relapsing course, the blast phenotype...